Log in

Ultralife Stock Price, Forecast & Analysis (NASDAQ:ULBI)

-0.09 (-0.98 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
Now: $9.08
50-Day Range
MA: $8.52
52-Week Range
Now: $9.08
Volume19,100 shs
Average Volume18,006 shs
Market Capitalization$144.01 million
P/E Ratio6.09
Dividend YieldN/A
Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. Read More…

Industry, Sector and Symbol

Industry Miscellaneous electrical machinery, equipment, & supplies
SectorComputer and Technology
Current SymbolNASDAQ:ULBI



Sales & Book Value

Annual Sales$87.19 million
Cash Flow$1.71 per share
Book Value$6.74 per share


Net Income$24.93 million


Market Cap$144.01 million
Next Earnings Date2/6/2020 (Estimated)

Receive ULBI News and Ratings via Email

Sign-up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.

Ultralife (NASDAQ:ULBI) Frequently Asked Questions

What is Ultralife's stock symbol?

Ultralife trades on the NASDAQ under the ticker symbol "ULBI."

How will Ultralife's stock buyback program work?

Ultralife declared that its board has approved a share repurchase program on Thursday, November 1st 2018, which allows the company to repurchase 2,500,000 shares, according to EventVestor. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company's board of directors believes its stock is undervalued.

How were Ultralife's earnings last quarter?

Ultralife Corp. (NASDAQ:ULBI) released its quarterly earnings data on Thursday, August, 2nd. The technology company reported $0.10 EPS for the quarter. The technology company earned $22.86 million during the quarter. Ultralife had a net margin of 24.12% and a return on equity of 22.91%. View Ultralife's Earnings History.

When is Ultralife's next earnings date?

Ultralife is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Ultralife.

Has Ultralife been receiving favorable news coverage?

News stories about ULBI stock have been trending very negative on Saturday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ultralife earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Ultralife.

Are investors shorting Ultralife?

Ultralife saw a increase in short interest in the month of October. As of October 15th, there was short interest totalling 122,800 shares, an increase of 9.8% from the September 15th total of 111,800 shares. Based on an average daily trading volume, of 21,300 shares, the short-interest ratio is presently 5.8 days. Approximately 1.3% of the shares of the stock are sold short. View Ultralife's Current Options Chain.

Who are some of Ultralife's key competitors?

What other stocks do shareholders of Ultralife own?

Who are Ultralife's key executives?

Ultralife's management team includes the folowing people:
  • Mr. Michael D. Popielec, CEO, Pres & Director (Age 57)
  • Mr. Philip A. Fain, CFO, Treasurer & Corp. Sec. (Age 64)

Who are Ultralife's major shareholders?

Ultralife's stock is owned by many different of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (4.25%), Essex Investment Management Co. LLC (1.10%), Teton Advisors Inc. (0.90%) and Shikiar Asset Management Inc. (0.11%). Company insiders that own Ultralife stock include Philip A Fain, Thomas Louis Saeli and W Shaw Robert. View Institutional Ownership Trends for Ultralife.

Which institutional investors are selling Ultralife stock?

ULBI stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC and Shikiar Asset Management Inc.. View Insider Buying and Selling for Ultralife.

Which institutional investors are buying Ultralife stock?

ULBI stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Teton Advisors Inc.. Company insiders that have bought Ultralife stock in the last two years include Philip A Fain, Thomas Louis Saeli and W Shaw Robert. View Insider Buying and Selling for Ultralife.

How do I buy shares of Ultralife?

Shares of ULBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Ultralife's stock price today?

One share of ULBI stock can currently be purchased for approximately $9.08.

How big of a company is Ultralife?

Ultralife has a market capitalization of $144.01 million and generates $87.19 million in revenue each year. View Additional Information About Ultralife.

What is Ultralife's official website?

The official website for Ultralife is http://www.ultralifecorp.com/.

How can I contact Ultralife?

Ultralife's mailing address is 2000 TECHNOLOGY PARKWAY, NEWARK NY, 14513. The technology company can be reached via phone at 315-332-7100.

MarketBeat Community Rating for Ultralife (NASDAQ ULBI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  149 (Thanks for Voting!)
Underperform Votes:  175 (Thanks for Voting!)
Total Votes:  324
MarketBeat's community ratings are surveys of what our community members think about Ultralife and other stocks. Vote "Outperform" if you believe ULBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ULBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/16/2019 by MarketBeat.com Staff

Featured Article: What are earnings reports?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel